Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

3α-Androstanediol Kinetics in Man
T. Kinouchi, R. Horton
T. Kinouchi, R. Horton
Published September 1, 1974
Citation Information: J Clin Invest. 1974;54(3):646-653. https://doi.org/10.1172/JCI107802.
View: Text | PDF
Research Article

3α-Androstanediol Kinetics in Man

  • Text
  • PDF
Abstract

Kinetics of 5α-androstane-3α, 17β-diol (3α-diol) were studied in man. Clearance rates were determined by both the constant infusion and single injection techniques. Production rates were calculated as the product of clearance rate data and plasma values in the a.m. obtained by a radioimmunoassay specific for 3α-diol. Mean metabolic clearance rates were 1,776±492 (SD) liters/day in males and 1,297±219 (SD) liters/day in females. Metabolic clearance rates by single injection were similar. Calculated production rates are 208±26 (SD) μg/day in males and 35±11 μg/day in females, which are significantly different. Hepatic extraction of 3α-diol determined by hepatic vein catheterization during constant infusion was 76% which was greater than expected from information on in vitro binding in plasma. The kinetic data is of interest since 3α-diol has a calculated inner pool (V1) volume of 12-14 liters, similar to 17β-hydroxyandrost-4-en-3-one (testosterone) and 5α-androstan-17β-ol-3-one (dihydrotestosterone), but the calculated outer pool (V2) of 33.5 liters is very large as are the metabolic rate and transfer constant. In contrast to testosterone and dihydrotestosterone, 3α-diol, although bound to sex hormone binding globulin, has a high metabolic clearance of which a large fraction represents extrahepatic (splanchnic) metabolism. A production rate of 3α-diol similar to dihydrotestosterone together with rather unique kinetic characteristics encourages further investigation of the biological role of this potent androgen.

Authors

T. Kinouchi, R. Horton

×

Total citations by year

Year: 2011 2010 2008 2006 2001 1998 1992 1990 1989 1988 1987 1986 1985 1984 1983 1982 1980 1979 1978 1977 1976 1975 Total
Citations: 1 1 1 1 1 1 1 1 3 2 2 3 1 2 1 3 2 4 1 1 1 1 35
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (35)

Title and authors Publication Year
Activation of the Androgen Receptor by Intratumoral Bioconversion of Androstanediol to Dihydrotestosterone in Prostate Cancer
JL Mohler, MA Titus, S Bai, BJ Kennerley, FB Lih, KB Tomer, EM Wilson
Cancer research 2011
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
Pre-receptor regulation of the androgen receptor
TM Penning, Y Jin, TL Rizner, DR Bauman
Molecular and Cellular Endocrinology 2008
Identification of the Major Oxidative 3α-Hydroxysteroid Dehydrogenase in Human Prostate That Converts 5α-Androstane-3α,17β-diol to 5α-Dihydrotestosterone: A Potential Therapeutic Target for Androgen-Dependent Disease
DR Bauman, S Steckelbroeck, MV Williams, DM Peehl, TM Penning
Molecular Endocrinology 2006
Unexpected Virilization in Male Mice Lacking Steroid 5α-Reductase Enzymes
MS Mahendroo, KM Cala, DL Hess, DW Russell
Endocrinology 2001
Pharmacokinetics and pharmacodynamics of FK143, a nonsteroidal inhibitor of steroid 5α-reductase, in healthy volunteers
M Katashima, T Irino, F Shimojo, A Kawamura, H Kageyama, N Higashi, Y Miyao, Y Tokuma, T Hata, K Yamamoto, Y Sawada, T Iga
Clinical Pharmacology & Therapeutics 1998
Dihydrotestosterone Is a Peripheral Paracrine Hormone
R Horton
Journal of andrology 1992
Clinical signs of androgen excess as risk factors for coronary artery disease*
RA Wild, B Grubb, A Hartz, JJ van Nort, W Bachman, M Bartholomew
Fertility and Sterility 1990
Precursors of plasma androstanediol- and androgen-glucuronides in women
VA Giagulli, L Verdonck, R Giorgino, A Vermeulen
Journal of Steroid Biochemistry 1989
The Polycystic Ovary Syndrome
JA Eden
The Australian and New Zealand Journal of Obstetrics and Gynaecology 1989
Estradiol and testosterone metabolism and production in men with prostatic cancer
AW Meikle, JA Smith, JD Stringham
Journal of Steroid Biochemistry 1989
Conversion of dihydrotestosterone to androstanediol glucuronide by female sexual skin
V Pasupuleti, R Lobo, R Horton
Steroids 1988
Markers of peripheral androgen action in vivo and in vitro
R Horton
Clinics in Dermatology 1988
Circulating dihydrotestosterone may not reflect peripheral formation
V Toscano, R Horton
Journal of Clinical Investigation 1987
Production, clearance, and metabolism of testosterone in men with prostatic cancer
AW Meikle, JA Smith, JD Stringham
The Prostate 1987
Determination of 5α-androstane-3α, 17β-diol and 5α-androstane-3β, 17β-diol in human plasma by selected ion monitoring
F Jacolot, D Picart, F Berthou, HH Floch
Biological Mass Spectrometry 1986
5 Dihydrotestosterone metabolism
V Toscano
Clinics in Endocrinology and Metabolism 1986
6 Peripheral androgens and the role of androstanediol glucuronide
R Horton, R Lobo
Clinics in Endocrinology and Metabolism 1986
Determination of 5α-androstane-3α,17β-diol and 5α-androstane-3β,17β-diol in human plasma by radioimmunoassay
F Jacolot, J Adeline, F Berthou, HH Floch
Journal of Steroid Biochemistry 1985
THE EFFECT OF ENDOGENOUS PROGESTERONE ON SERUM LEVELS OF 5α-REDUCED ANDROGENS IN HIRSUTE WOMEN
P Dewis, M Newman, DC Anderson
Clinical Endocrinology 1984
Benign Prostatic Hyperplasia: A Disorder of Androgen Metabolism in the Male
R Horton
Journal of the American Geriatrics Society 1984
A comparison of androgen production and clearance in hirsute and obese women
MA Kirschner, E Samojlik, D Silber
Journal of Steroid Biochemistry 1983
3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism
R Horton, D Hawks, R Lobo
Journal of Clinical Investigation 1982
Conversion of Progesterone from the Adrenal or Ovary to Deoxycorticosterone in Plasma
I Antonlpillal, E Moghissi, SD Frasler, R Horton
Clinical and Experimental Hypertension 1982
The Endocrinology of Prostate Tumours
R Ghanadian
1982
Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia
I Morimoto, A Edmiston, R Horton
Journal of Clinical Investigation 1980
Measurement of 5α-androstane-3α,17β-diol in human spermatic venous plasma by mass-fragmentography
G Moneti, M Pazzagli, G Fiorelli, M Serio
Journal of Steroid Biochemistry 1980
Androgen Metabolism by Rat Epididymis: Metabolic Conversion of3H-Dihydrotestosterone In Vivo and In Vitro
CD Hastings, O Djøseland
Systems Biology in Reproductive Medicine 1979
Decline in sexual activity in ageing men: correlation with sex hormone levels and testicular changes
A Vermeulen
Journal of Biosocial Science 1979
Hormonal Steroids
W Nowaczynski, P Landais, T Murakami, M Nowaczynski, D Mavoungou, B Vitullo
Hormonal Steroids 1979
Metabolism of androgens by the baboon kidney
O Jiro, O Yoshio, RY Kirdani, AA Sandberg
Journal of Steroid Biochemistry 1979
Sex Steroid Production and Secretion in the Male*,**
R Horton
Andrologia 1978
Metabolism of 5α-dihydrotestosterone in human benign hyperplastic prostate
K Malathi, E Gurpide
Journal of Steroid Biochemistry 1977
Measurement of Androstanediol in Plasma in a Radioimmunoassay using Celite Column Chromatography**Supported by Grant AM 13710 from the National Institutes of Health
J Barberia, L Pages, R Horton
Fertility and Sterility 1976
In vivo metabolism of 3H-dihydrotestosterone and 3H-androstanediol in adult male rats
EJ Doorn, B Burns, D Wood, CE Bird, AF Clark
Journal of Steroid Biochemistry 1975

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts